Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial)

Overview of attention for article published in BMC Cancer, December 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 636 followers.

Martinez Chanza, N.-Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle i... https://t.co/OX0ZPoCjLV

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.